These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24631953)

  • 1. Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction.
    Pei Z; Ma D; Ji L; Zhang J; Su J; Xue W; Chen X; Wang W
    Peptides; 2014 May; 55():131-5. PubMed ID: 24631953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction].
    Ji L; Pei ZQ; Ma DF; Zhang J; Su JS; Gao XD; Xue WZ; Chen XP; Wang WS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Nov; 40(11):914-9. PubMed ID: 23363671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels and potential roles of catestatin in patients with coronary heart disease.
    Liu L; Ding W; Zhao F; Shi L; Pang Y; Tang C
    Scand Cardiovasc J; 2013 Aug; 47(4):217-24. PubMed ID: 23688154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling.
    Meng L; Wang J; Ding WH; Han P; Yang Y; Qi LT; Zhang BW
    Postgrad Med J; 2013 Apr; 89(1050):193-6. PubMed ID: 23223776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different treatment interventions affect plasma NT-ProBNP levels and early exercise tolerance in patients with acute ST-segment elevation myocardial infarction.
    Wu XL; Zhu R; Jiang H; Li B
    Postgrad Med; 2012 Mar; 124(2):58-63. PubMed ID: 22437216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
    Walter T; Brueckmann M; Lang S; Sauer T; Fiedler E; Papassotiriou J; Behnes M; Elmas E; Borggrefe M; Bertsch T
    Clin Lab; 2010; 56(7-8):303-9. PubMed ID: 20857894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.
    Chong CP; Lim WK; Velkoska E; van Gaal WJ; Ryan JE; Savige J; Burrell LM
    Am J Cardiol; 2012 May; 109(9):1365-73. PubMed ID: 22381157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
    Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction.
    Wang X; Xu S; Liang Y; Zhu D; Mi L; Wang G; Gao W
    Biomarkers; 2011 Jun; 16(4):372-7. PubMed ID: 21545240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
    van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
    Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Administration of Catestatin Improves Autonomic Function and Exerts Cardioprotective Effects in Myocardial Infarction Rats.
    Wang D; Liu T; Shi S; Li R; Shan Y; Huang Y; Hu D; Huang C
    J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):526-535. PubMed ID: 26821570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
    J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
    Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.